4-121678468-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001154.4(ANXA5):c.421G>A(p.Val141Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000208 in 1,613,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001154.4 missense
Scores
Clinical Significance
Conservation
Publications
- pregnancy loss, recurrent, susceptibility to, 3Inheritance: Unknown Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152218Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000957 AC: 24AN: 250678 AF XY: 0.0000886 show subpopulations
GnomAD4 exome AF: 0.000197 AC: 288AN: 1461428Hom.: 0 Cov.: 31 AF XY: 0.000193 AC XY: 140AN XY: 726990 show subpopulations
GnomAD4 genome AF: 0.000309 AC: 47AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000295 AC XY: 22AN XY: 74484 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.421G>A (p.V141M) alteration is located in exon 7 (coding exon 6) of the ANXA5 gene. This alteration results from a G to A substitution at nucleotide position 421, causing the valine (V) at amino acid position 141 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at